当前位置：药药网 / 药品 / 美国NDC未完成药物数据库文件(本栏目收费,不能显示细节,电话13136136841)
药品名称： 商品名称： 药品NDC： 上市日期： -格式:2020-5-3
注册申请号： 市场分类： 活性成分： 持证企业：
 美国NDC未完成药物数据库文件19583条(本栏目收费,不能显示细节,电话13136136841)
药品名称(分析)
商品名
药品NDC
专利人(分析)
上市日期
活性成分
市场分类
规格(分析)
申请号
Ambrisentan
DRUG FOR FURTHER PROCESSING
0591-2405
Actavis Pharma, Inc.
2019/3/28 0:00:00
AMBRISENTA
DRUG FOR FURTHER PROCESSING
5
0591-2405_
Ambrisentan
DRUG FOR FURTHER PROCESSING
0591-2406
Actavis Pharma, Inc.
2019/3/28 0:00:00
AMBRISENTA
DRUG FOR FURTHER PROCESSING
10
0591-2406_
Tetracycline Hydrochloride
DRUG FOR FURTHER PROCESSING
0591-2474
Actavis Pharma, Inc.
2011/8/15 0:00:00
TETRACYCLI
DRUG FOR FURTHER PROCESSING
250
0591-2474_
Tetracycline Hydrochloride
DRUG FOR FURTHER PROCESSING
0591-2475
Actavis Pharma, Inc.
2011/8/15 0:00:00
TETRACYCLI
DRUG FOR FURTHER PROCESSING
500
0591-2475_
bosentan
DRUG FOR FURTHER PROCESSING
0591-2511
Actavis Pharma, Inc.
2019/6/3 0:00:00
BOSENTAN
DRUG FOR FURTHER PROCESSING
62.5
0591-2511_
bosentan
DRUG FOR FURTHER PROCESSING
0591-2512
Actavis Pharma, Inc.
2019/6/3 0:00:00
BOSENTAN
DRUG FOR FURTHER PROCESSING
125
0591-2512_
Chlorzoxazone
DRUG FOR FURTHER PROCESSING
0591-2520
Actavis Pharma, Inc.
2011/8/22 0:00:00
CHLORZOXAZ
DRUG FOR FURTHER PROCESSING
500
0591-2520_
Metronidazole
DRUG FOR FURTHER PROCESSING
0591-2521
Actavis Pharma, Inc.
2011/8/22 0:00:00
METRONIDAZ
DRUG FOR FURTHER PROCESSING
250
0591-2521_
Potassium Citrate
DRUG FOR FURTHER PROCESSING
0591-2682
Actavis Pharma, Inc.
2018/5/30 0:00:00
POTASSIUM
DRUG FOR FURTHER PROCESSING
5
0591-2682_
Albendazole
DRUG FOR FURTHER PROCESSING
0591-2712
Actavis Pharma, Inc.
2019/6/13 0:00:00
ALBENDAZOL
DRUG FOR FURTHER PROCESSING
200
0591-2712_
Potassium Citrate
DRUG FOR FURTHER PROCESSING
0591-2729
Actavis Pharma, Inc.
2018/5/30 0:00:00
POTASSIUM
DRUG FOR FURTHER PROCESSING
10
0591-2729_
Potassium Citrate
DRUG FOR FURTHER PROCESSING
0591-2742
Actavis Pharma, Inc.
2018/5/30 0:00:00
POTASSIUM
DRUG FOR FURTHER PROCESSING
15
0591-2742_
Clindamycin Hydrochloride
DRUG FOR FURTHER PROCESSING
0591-2932
Actavis Pharma, Inc.
2014/9/9 0:00:00
CLINDAMYCI
DRUG FOR FURTHER PROCESSING
300
0591-2932_
Docosanol
DRUG FOR FURTHER PROCESSING
0591-2981
Actavis Pharma, Inc.
2019/4/5 0:00:00
DOCOSANOL
DRUG FOR FURTHER PROCESSING
100
0591-2981_
Nizatidine
DRUG FOR FURTHER PROCESSING
0591-3137
Actavis Pharma, Inc.
2002/7/9 0:00:00
NIZATIDINE
DRUG FOR FURTHER PROCESSING
150
0591-3137_
Nizatidine
DRUG FOR FURTHER PROCESSING
0591-3138
Actavis Pharma, Inc.
2002/7/9 0:00:00
NIZATIDINE
DRUG FOR FURTHER PROCESSING
300
0591-3138_
Minocycline Hydrochloride
DRUG FOR FURTHER PROCESSING
0591-3153
Actavis Pharma, Inc.
1999/6/10 0:00:00
MINOCYCLIN
DRUG FOR FURTHER PROCESSING
75
0591-3153_
Ursodiol
DRUG FOR FURTHER PROCESSING
0591-3159
Actavis Pharma, Inc.
1987/12/31 0:00:00
URSODIOL
DRUG FOR FURTHER PROCESSING
300
0591-3159_
Galantamine
DRUG FOR FURTHER PROCESSING
0591-3496
Actavis Pharma, Inc.
2008/12/15 0:00:00
GALANTAMIN
DRUG FOR FURTHER PROCESSING
8
0591-3496_
Galantamine
DRUG FOR FURTHER PROCESSING
0591-3497
Actavis Pharma, Inc.
2008/12/15 0:00:00
GALANTAMIN
DRUG FOR FURTHER PROCESSING
16
0591-3497_
网站地图 - 网站开发 - 网站简介 - 会员服务 - 法律声明 - 联系我们 - 药品招商频道 - 药品信息排行 - 2018年版国家基本药物目录 - 意见反馈
免责声明：以上所展示的信息由企业自行提供，内容的真实性、准确性和合法性由发布企业负责，医药网对此不承担任何责任。
相关链接：医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究　　客服热线：0575-83552251 / 13754370441  QQ客服：药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证：浙B2-20220931　互联网药品信息服务资格证书编号：(浙)-经营性2023-0215　浙公网安备:330683240604819103159
　医药代理商群１：药药网药品采购交流医药代理商群２：药药网药品采购交流2医药代理商群３：药药网药品采购交流3